EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
30 Agosto 2023 - 8:00AM
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical
company committed to developing and commercializing therapeutics to
improve the lives of patients with serious eye disorders, today
announced that the Company will participate at the following
upcoming conferences:
- Citi's
18th Annual BioPharma
ConferenceForum: 1x1 Investor MeetingsDate: Wednesday,
September 6, 2023
- H.C. Wainwright
25th Annual Global Investment
ConferenceForum: Corporate PresentationDate: Monday,
September 11, 2023Time: Available on-demand at 7:00 a.m. ET
- Baird 2023 Global
Healthcare ConferenceForum: Fireside ChatDate: Wednesday,
September 13, 2023Time: 12:50 p.m. ET
- 2023 Cantor Fitzgerald Global
Healthcare ConferenceForum: Fireside ChatDate: Tuesday,
September 26, 2023Time: 1:15 p.m. ET
- JonesTrading 2023 Healthcare
SummitForum: Panel DiscussionDate: Tuesday, October 10,
2023Time: 1:45 p.m. ET
A webcast and subsequent archived replay of the
presentations and panel discussion may be accessed via the
Investors section of the Company website at
www.eyepointpharma.com.
About EyePoint
Pharmaceuticals
EyePoint Pharmaceuticals (Nasdaq: EYPT) is a
company committed to developing and commercializing therapeutics to
help improve the lives of patients with serious eye disorders. The
Company's pipeline leverages its proprietary erodible Durasert E™
technology for sustained intraocular drug delivery including
EYP-1901, an investigational sustained delivery intravitreal
anti-VEGF treatment currently in Phase 2 clinical trials. The
proven Durasert® drug delivery platform has been safely
administered to thousands of patients' eyes across four U.S. FDA
approved products. EyePoint Pharmaceuticals is headquartered in
Watertown, Massachusetts. For more information visit
www.eyepointpharma.com.
Investors:Christina
TartagliaStern IRDirect:
212-698-8700christina.tartaglia@sternir.com
Media ContactAmy PhillipsGreen
Room CommunicationsDirect:
412-327-9499aphillips@greenroompr.com
EyePoint Pharmaceuticals (NASDAQ:EYPT)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
EyePoint Pharmaceuticals (NASDAQ:EYPT)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024